At the heart of equitable healthcare lies a critical truth: representation matters.  BlackDoctor.org spoke with Dr. Adrelia ...

Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.

One of the few drug trials for a possible long Covid ended in disappointment. But lessons are leading to a second chance.

A new study reveals an alarming number of mechanisms throughout the life-cycle of plastic that could enhance or spread ...

Medpace beats Q2 2025 earnings, raises FY guidance, showcasing strong biotech demand. Click here to read an analysis of MEDP ...

The Vision Center at Children’s Hospital Los Angeles is developing a protocol for a phase 1 clinical trial for the first gene ...

Data from the KEYNOTE-B61 trial show tumor shrinkage in different types of kidney cancer, including papillary and chromophobe ...

For decades, the narrative around Parkinson’s disease treatment has focused primarily on dopamine replacement. The loss of dopaminergic neurons in the substantia nigra is well recognized and drives ...

A nationwide clinical trial is offering renewed hope to thousands of Georgia families affected by Alzheimer’s disease.

ASCO 2025 showcases breakthroughs in sarcoma treatment, emphasizing precision medicine, immunotherapy, and promising new ...

Sarepta officials said the temporary halt in shipments was done to maintain a productive working relationship with regulators ...

When it comes to birth control, the market has long been skewed: female contraception comes in a variety of pills, implants, ...